Admission Date:  [**2103-9-6**]              Discharge Date:   [**2103-9-10**]  Date of Birth:  [**2026-4-10**]             Sex:   M  Service: MEDICINE  Allergies: Zithromax / Erythromycin Base  Attending:[**First Name3 (LF) 13541**] Chief Complaint: Melena and hypotension  Major Surgical or Invasive Procedure: Upper Endoscopy Duodenal ulcer biopsy and cauterization   History of Present Illness: This is a 77 yo M with h/o DM II, dementia, HTN, COPD, and recent admission for cellulitis on Levo/Flagyl/Bactrim who presents from Nursing home with melena and hypotension.
Patient reports one episode of melena yesterday which he describes as black loose stool.
He denies any hematochezia, BRBPR, bloody or coffee ground emesis, abdominal pain, fevers, or chills.
Patient was given 1u PRBC, NG lavage showed coffee ground emesis which cleared with 200cc lavage.
Chronic renal impairment.
Peripheral vascular disease s/p stent to left SFA, s/p therectomy and PTA of the right 5.
Atrial fibrillation.
Chronic obstructive pulmonary disease.
CAD s/p stents on Plavix   Social History: Currently lives in Stone [**Hospital3 **] home.
Family History: Not obtained  Physical Exam: VS: BP 115/69  HR 91  RR 12  95% RA GEN: AAO X 3, lethargic, responds to verbal stimuli HEENT: EOMI, PERRLA, dry mucous membranes, OP clear NECK: Supple, no JVD appreciated CV: normal S1, S2.
no m/r/g appreciated CHEST: +minor crackles at bilateral bases, +mild expiratory wheezes ABD: Soft, NT, ND, no HSM, normoactive BS EXT: no peripheral edema, +1 distal pulses SKIN: erythema noted over bilateral lower shins, warm to touch, several overlying healing skin ulcers, no pus.
MODERATE GROWTH.
Please contact the Microbiology Laboratory ([**7-/2401**])immediately if sensitivity to clindamycin is required on this patient's isolate.
[**2103-9-6**] 01:25AM   WBC-11.9* RBC-3.11* HGB-9.1*# HCT-29.1* MCV-94 MCH-29.4 MCHC-31.4 RDW-14.0 [**2103-9-6**] 01:25AM   NEUTS-74.7* LYMPHS-18.8 MONOS-5.4 EOS-0.8 BASOS-0.3 [**2103-9-6**] 01:25AM   PLT COUNT-449*# [**2103-9-6**] 01:25AM   PT-15.6* PTT-25.6 INR(PT)-1.4* [**2103-9-6**] 01:25AM   ALT(SGPT)-23 AST(SGOT)-25 ALK PHOS-83 TOT BILI-0.3 [**2103-9-6**] 01:25AM   GLUCOSE-86 UREA N-51* CREAT-1.0 SODIUM-138 POTASSIUM-5.1 CHLORIDE-102 TOTAL CO2-31 ANION GAP-10 [**2103-9-6**] 01:31AM   HGB-9.8* calcHCT-29 [**2103-9-6**] 05:45AM   HGB-9.3* HCT-28.0* [**2103-9-6**] 08:39AM   HGB-10.0* calcHCT-30  Brief Hospital Course: 77 yo M with h/o CAD, DM II, PVD, COPD, cellulitis, who presented with melena and hypotension, and underwent embolization after duodenal ulcers were identified.
# Melena: Patient with melena x 1, along with hypotension at nursing home and HCT drop from 37.3 on [**9-1**] to 29.1.
After discussion with GI, decision was made to continue plavix given pt's CAD s/p stents, but ASA was decreased from 325 to 81 mg. Pt should discuss resumption of full dose ASA with his PCP.
# CAD s/p stents - Pt s/p PCI of LAD in [**6-/2103**] with 2 Bare Metal Stents.
We advise that the patient's PCP consider [**Name9 (PRE) 18290**] his ACE-I as outpatient if pressures remain stable.
# DM II - Pt continued on half dose NPH while NPO.
# Atrial fibrillation - Hx of afib, not on coumadin.
# PVD - History of SFA stent: Continued plavix, decreased ASA dose as above.
# Dementia - Held aricept, paroxetine while NPO, these were reintroduced at the end of his course.
# Sacral Ulcer:  Pt was seen by wound care.
Disp:*30 * Refills:*0*   Discharge Disposition: Extended Care  Facility: [**Hospital6 4657**] - [**Location 1268**]  Discharge Diagnosis: Bleeding duodenal ulcer Lower extremity ulcers and cellulitis Chronic atrial fibrillation Stable coronary artery disease Chronic systolic heart failure Diabetes type 2, controlled, with complications Hyperlipidemia Chronic obstructive pulmonary disease Hypertension  Discharge Condition: Good   Discharge Instructions: Please take all your medications as prescribed.
Please return for fever, chest pain, shortness of breath, shaking chills, blood in urine or stool, non-healing wounds or ulcers, or any other  concerning symptom.
